Quantori, a global data science and digital transformations solutions provider for life science and healthcare organizations, partnered with a leading data lakehouse company, Databricks, to accelerate innovation throughout the entire drug lifecycle by combining data, analytics, and AI on a simple and open multi-cloud platform.
Richard Golob, CEO, Quantori, said, “Technology is a key driver of innovation in the life sciences and is transforming pharma R&D. We are excited that Quantori has become an official Databricks Consulting Partner to help biopharma customers accelerate their research and improve health outcomes with the power of data and AI. Our data scientists and ML engineers have extensive experience in data migration to the Databricks Lakehouse Platform, plus a deep domain knowledge in life sciences required for facilitating successful RWE studies that increase speed to market.”
With its simple and open architecture for data and AI, Databricks has helped most organizations that already store their data in data lakes to benefit from the reliability, governance, and performance of a data warehouse. Databricks Partners are assisting clients in developing lakehouse systems on AWS, Microsoft Azure, and Google Cloud to support every data and analytics use case, from data warehousing and business intelligence to data engineering and AI/ML workloads.
“Databricks is a pioneer of the data lakehouse paradigm which tackles the big data challenges in healthcare and life sciences, such as data silos and fragmented patient data and the ability to gain real-time insights to inform treatment decisions. Partnering with Databricks supports Quantori’s goal of being the bridge between science and patient success by helping customers streamline the data management lifecycle to accelerate innovation and translate science from the lab to the clinic”, stated Solman Rahman, Executive Vice President for Europe, Quantori.